NUCB2 and gestational diabetes: The univariate linear regression model revealed that an increase of serum levels of nesfatin-1 and vaspin by 1 ng/mL decreased the incidence of the GDM by 9.85% and 47.66%, respectively (CI 95%, OR:0.9015 vs. 0.5234).